• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Schmallenberg-virus: ELISA kit validated in France

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
computertranslation

april 10, 2012

Schmallenberg virus: Validation of an ELISA kit


An ELISA kit for serological diagnosis SBV has been approved by the Animal Health Laboratory of Anses Maisons-Alfort.

Serological tests are essential for epidemiological surveillance and conduct epidemiological surveys. The antibodies can be detected by serum neutralization or immunofluorescence but these techniques are slow to implement, difficult to perform on a large number of samples and do not allow a standardized interpretation of results.

Therefore, knowledge about the prevalence of infection in outbreaks of SBV were limited so far ... and those in the infected herds unrecognized non-existent. During the week of April 2, 2012, the Animal Health Laboratory Maisons-Alfort, after a collaborative study, validated indirect ELISA, developed and produced by IDvet ?, based on a recombinant protein of SBV.

This kit is being validated by any other national reference laboratories in Europe.

External validation studies of this test indicate excellent specificity (99.75% - 95% CI [99.26 to 99.92%], n = 1179), and a very good sensitivity (96.47% - [95% CI: 93.43% - 98.13%], n = 255). This will now allow to consider specifically the implementation of large-scale epidemiological studies to estimate the magnitude and extension of infection in flocks of ruminants.

survepi
 
Back
Top